NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning software, which addresses the key gaps in the prediction of bona fide immunogenic antigens for personalized cancer immunotherapy and infectious disease vaccines.
We are dedicated to developing scalable software solutions that facilitate effective patient selection for cancer immunotherapy, and identifying optimal neoantigen targets for truly personalized cancer vaccines & cell therapies in a clinically actionable time frame.
Our growing international team (13 countries and counting!) consists of a diverse mix of data scientists, bioinformaticians, immunologists, cancer researchers, and software developers.
NEC OncoImmunity AS is a subsidiary of the NEC Corporation, and is based in the Oslo Cancer Cluster buildings in Oslo, Norway.
Company Details
- Employees
- 43
- Founded
- -
- Address
- Ullernchausséen 64, Oslo,oslo 0379,norway
- Industry
- Biotechnology
- Website
- oncoimmunity.com
- HQ
- Oslo, Oslo
Nec Oncoimmunity As Questions
Nec Oncoimmunity As's website is oncoimmunity.com
Nec Oncoimmunity As's LinkedIn profile is https://no.linkedin.com/company/oncoimmunity
Nec Oncoimmunity As has
43 employees.
View email and phone details for 43
employees at Nec Oncoimmunity As.
Nec Oncoimmunity As's industry is
Biotechnology
Nec Oncoimmunity As's top competitors are
Nec Bio B.v.,
Barrington James,
Mindshare Norway,
Nec Corporation,
Transgene,
Oncoinvent Asa,
Nykode Therapeutics,
Norwegian Centre For Molecular Biosciences And Medicine (Ncmbm), University Of Oslo,
Bostongene,
Nec Bio Therapeutics Gmbh.
Nec Oncoimmunity As's categories are Biotechnology
Nec Oncoimmunity As's founding year is 2014
